These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 985576)

  • 1. Differential effects of tranylcypromine and pargyline on indoleamines in brain.
    Tabakoff B; Moses F
    Biochem Pharmacol; 1976 Dec; 25(23):2555-60. PubMed ID: 985576
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tranylcypromine and pargyline on brain tryptamine.
    Tabakoff B; Moses F; Philips SR; Boulton AA
    Experientia; 1977 Mar; 33(3):380-1. PubMed ID: 870336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of morphine tolerance and dependence from brain serotonin synthesis rate in mice.
    Schechter PJ; Lovenberg W; Sjoerdsma A
    Biochem Pharmacol; 1972 Mar; 21(5):751-3. PubMed ID: 5063173
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine oxidase inhibition and recovery in the mouse brain at various ages after birth.
    Samsa JM; Baker PC; Hoff KM
    Biol Neonate; 1979; 35(5-6):249-54. PubMed ID: 476197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of brain monoamine and locomotor activity in rats.
    Foldes A; Costa E
    Biochem Pharmacol; 1975 Sep; 24(17):1617-21. PubMed ID: 1191320
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain amine content and functional maturity in the fowl: the effects of pargyline.
    Watts JS; Mendez HC; Reilly JF; Krop S
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):130-6. PubMed ID: 5353467
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 10. [Excitormotor effects of tryptamine, in presence of IMAO, in mice pretreated with enzymatic inducers].
    Denys A; Levy J; Michel-Ber E
    Therapie; 1969; 24(5):907-22. PubMed ID: 4391432
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of serotonin biosynthesis by 6-halotryptophans in vivo.
    Peters DA
    Biochem Pharmacol; 1971 Jul; 20(7):1413-20. PubMed ID: 5163081
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective brain monoamine oxidase inhibition resulting from an interaction between reversible and irreversible inhibitors.
    Horita A
    Int J Neuropharmacol; 1965 Nov; 4(6):337-42. PubMed ID: 4379937
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of chlorpromazine on brain serotonin turnover and body temperature in isolated aggressive mice.
    Goldberg ME; Dubnick B; Hefner M; Salama AI
    Neuropharmacology; 1973 Mar; 12(3):249-60. PubMed ID: 4735416
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of psychoactive drugs on in vivo metabolism of 14C-histamine in mouse brain.
    Schayer RW; Reilly MA
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):123-9. PubMed ID: 4725329
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of acutely administered analgesic drugs on rat brain serotonin turnover.
    Goodlet I; Sugrue MF
    Eur J Pharmacol; 1974 Dec; 29(2):241-8. PubMed ID: 4442443
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases.
    Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ
    Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the tranylcypromine-meperidine interaction: effects of p-chlorophenylalanine and l-5-hydroxytryptophan.
    Gessner PK; Soble AG
    J Pharmacol Exp Ther; 1973 Aug; 186(2):276-87. PubMed ID: 4268957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.